Hydrochlorothiazide
- Product NDC
- 0615-1561
- 11-digit product format
- 006151561
- Labeler code
- 0615
- Product ID
- 0615-1561_e4155f64-58c6-43d2-a944-cad2b13e78ae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA040412
- Marketing category
- ANDA
- Marketing start
- 2002-03-29
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-1561-05 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |
| 0615-1561-30 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |
| 0615-1561-39 | 2021-06-14 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |
| 0615-1561-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |
| 0615-1561-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |
| 0615-1561-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2dfd-f424-e053-dadaa90a57ce | 5e168199-0f9a-48ab-8893-dddd6b217ec0 |